Doxorubicin
DOXIL, Doxorubicin Hydrochloride, Doxorubicin Hydrochloride Liposome, doxorubicin hydrochloride, Liposomal
Anthracycline Topoisomerase Inhibitor
NADAC/unit
N/A
No Shortage
15 Manufacturers
30 ANDAs
Market Intelligence
2023-10-25 Class II Recall: Baxter Healthcare Corporation
Generic Manufacturers
ACTAVIS INCALEMBIC PHARMACEUTICALS LTDAMNEAL EU LTDAYANA PHARMA LTDBAXTER HEALTHCARE CORPDR REDDYS LABORATORIES LTDFRESENIUS KABI USA LLCGLAND PHARMA LTDHIKMA PHARMACEUTICALS USA INCLUPIN INCMYLAN LABORATORIES LTDPFIZER INCQILU PHARMACEUTICAL HAINAN CO LTDSAGENT PHARMACEUTICALS INCSUN PHARMACEUTICAL INDUSTRIES LTDZYDUS LIFESCIENCES GLOBAL FZE
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.